Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women

Fibroblast growth factor 23: state of the field and future directions

(2012) Nisan Bhattacharyya et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Effect of Intravenous Saccharated Ferric Oxide on Serum FGF23 and Mineral Metabolism in Hemodialysis Patients

(2011) Yoko Takeda et al.   AMERICAN JOURNAL OF NEPHROLOGY

FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease

(2011) Rayko Evstatiev et al.   GASTROENTEROLOGY

Iron Modifies Plasma FGF23 Differently in Autosomal Dominant Hypophosphatemic Rickets and Healthy Humans

(2011) Erik A. Imel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice

(2011) E. G. Farrow et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

FGF-23: More than a regulator of renal phosphate handling?

(2010) Harald Jüppner et al.   JOURNAL OF BONE AND MINERAL RESEARCH

A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients

(2010) Wajeh Y. Qunibi et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Severe Hypophosphatemia After Intravenous Administration of Iron Carboxymaltose in a Stable Renal Transplant Recipient

(2010) Laila-Yasmin Mani et al.   TRANSPLANTATION

Ferric Carboxymaltose

(2009) Katherine A. Lyseng-Williamson et al.   DRUGS

FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective Study

(2009) Belinda J. Schouten et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

BLOOD MANAGEMENT: Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial

(2009) David B. Van Wyck et al.   TRANSFUSION

Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia

(2009) B. J Schouten et al.   ANNALS OF CLINICAL BIOCHEMISTRY

A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT®) Randomized Controlled Trial

(2008) Stefanie Kulnigg et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial

(2008) Melvin H. Seid et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia

(2008) Christian Breymann et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

(2008) Orlando M. Gutiérrez et al.   NEW ENGLAND JOURNAL OF MEDICINE